Klinische Studie

Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer

NCT: NCT07781852 · NOT_YET_RECRUITING

NCT-IDNCT07781852

Medizinische Daten: StatusNOT_YET_RECRUITING

Startdatum2026-09-01

Abschluss2027-09-01

SponsorLumina Pharmaceuticals Inc (INDUSTRY)

First posted2026-08-24

Last updated2026-08-28

Kurzzusammenfassung

The objective of this study is to assess two novel positron emission tomography (PET) radiotracers, \[64Cu\]CM500 and \[68Ga\]CM500, for Positron Emission Tomography-Magnetic Resonance Imaging (PET-MR) and Positron Emission Tomography / Computed Tomography (PET-CT) imaging of solid tumors. These tracers have the potential to detect solid tumors throughout the body and may enable doctors to identify smaller tumors than conventional imaging techniques.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.